ReviewFrontiers in cell and developmental biology2026
From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging Molecular Targets and Recent Advancements for the Management of Depression.Molecular neurobiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychiatric disorders are increasingly viewed as network-level brain diseases resulting from disruptions in neural signaling across various hierarchies, including molecular, synaptic, circuit, and systems levels. Evidence indicates that receptor dysregulation, abnormal intracellular pathways, and changes in ion channel activity lead to widespread network dysconnectivity, resulting in cognitive, emotional, and behavioral deficits. This review integrates advancements in genomics, transcriptomics, connectomics, and computational modeling to establish a framework for understanding signaling abnormalities in major psychiatric disorders. Further, this study investigates essential molecular and cellular processes such as synaptic plasticity, receptor-mediated communication, intracellular signaling cascades, and neuroimmune interactions, and connects these to disturbances in oscillatory dynamics, circuit architecture, and overall brain network organization. Additionally, neuroimaging and graph-theoretic studies consistently demonstrate an excitation-inhibition imbalance, atypical synaptic pruning, impaired oscillatory synchrony, and maladaptive connectivity within networks, including the default mode, salience, and fronto-limbic systems, across schizophrenia, depression, bipolar disorder, anxiety, and autism spectrum disorders. Moreover, genetic and epigenetic variations in signaling genes, such as CACNA1C, GRIN2B, and DISC1, along with developmental and environmental factors, contribute to network vulnerability and clinical heterogeneity. Emerging artificial intelligence and multimodal integration methods facilitate the identification of individualized "signaling fingerprints," which connect molecular perturbations to systems-level dysfunction. This research enhances precision psychiatry and guides targeted interventions based on neuromodulation, molecular mechanisms, and biomarkers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.